Intellectual Property TA Lead, Vaccines (Hybrid)
- Employer
- CSL Seqirus
- Location
- Waltham
- Salary
- Competitive
- Posted
- Nov 10, 2024
- Closes
- Nov 21, 2024
- Practice
- Litigation
- Position
- Trademark Agent
- Contract Type
- Permanent
The Opportunity:
The TA Lead has significant responsibility and impact. The position will be instrumental in forming strategic partnerships with the respective business leads/TA leads. The TA Lead will lead and oversee the global management of intellectual property matters as well as provide strategic guidance to advance the TA IP assets and creating commercial business value and commercial security and confidence.
This role is integral to developing, defending and enforcing the organization's global TA patent portfolio, developing and enforcing the global TA's Regulatory exclusivities' portfolio, as well as ensuring compliance with intellectual property laws, thereby supporting the company's broader business objectives.
You will lead and support all IP aspects of deals planned and executed by the TA's. You will partner with the TA lead and associates on developing life cycle management and life cycle initiatives which involve IP amongst other things.
The Vaccines TA lead may also act as Head of Seqirus IP and primary point of contact for Seqirus management (if required).
The Role:
Strategic advisor to the IP function and key IP partner for CSL Therapeutic Area Leadership teams and TA–aligned development and commercial stakeholders (Immunoglobins, Vaccines, Hematology, Cardiovascular Renal, Immunology & Transplant) as well as to the corresponding commercial BU stakeholders.
Responsible for setting, managing and delivering on IP strategy and other enterprise–wide IP objectives to TA Leadership Team and senior BU stakeholders as well as other key stakeholders for TA–aligned products, including relating to clinical development, commercial activities, parallel import, exclusivities (regulatory data exclusivity, orphan drug exclusivity, pediatric exclusivity, PTE/SPC), labelling, life cycle management, country support, communications, patent listings, and LoE preparedness.
Managing a specialized team of TA–aligned patent attorneys, senior patent attorneys, IP lawyers, scientists, and life sciences lawyers to deliver enterprise–wide IP strategy supporting CSL Therapeutic Areas and TA–aligned activities and developing life cycle initiatives to actively contributor to the TA's value creation and long–term projections.
Within a matrix work model, leading and managing cross–functional team of attorneys and IP experts to deliver IP strategy and advice (as required) to management and other stakeholders
Overseeing and supporting the prosecution and leading defense of CSL intellectual property, including the identification and safeguarding of inventions relating to TA–aligned products and activities (SG2–SG7), management of TA–aligned patent portfolio with respect to pending applications and granted patents taking into account national and international law and guidelines.
Key business partner for senior leadership, commercial and R&D divisions in assessing and leading and strategically managing potential IP challenges relating to TA–aligned development and commercial products. Strategic lead, oversight and input for patent disputes, including patent office challenges as well as court litigations (infringement and revocation lawsuits) relating to TA–portfolio products; advising Head of IP, CSL Legal Leadership team and senior stakeholders and instructing external counsel on such matters as needed.
Provide counsel and IP advice to CSL Strategy team and TA–leadership team and assessing business impact of a potential asset from an IP perspective, including global licensing and business development, in due diligences, deal teams, and negotiation of agreements, such as, licensing & M&A.
Advises and represents the organization on legal issues concerning patent and related IP Issues, especially relating to TA–aligned products and TA–led activities.
The Vaccines TA lead may also act as Head of Seqirus IP and primary point of contact for Seqirus management (if required).
Key Relationships (both internal and external):
IP team, including Head of IP and IP Leadership Team
Therapeutic Area Leadership Team (TA LT)
Commercial Development
Clinical Development
Global Regulatory Affairs (GRA)
Safety / Tox
Strategy / Global Licensing for TA–led activities
Product Strategy Teams (PST), where required
Global Brand Teams (GBTs), where required
Skills & Experience:
Master's degree in life sciences discipline (chemistry, biochemistry, biotechnology) or a related field, preferably a PhD, or equivalent experience in scientific research. J.D. with experience in Patent Law
Qualified Patent Attorney or IP lawyer admitted to practice in the US or equivalent legal qualifications and experience in Intellectual Property
At least 12 years post–qualification experience in Intellectual Property
At least 5 years of experience with life science technologies and operations of in–house IP teams with a background in a technical field relevant to CSL, especially therapeutic areas of interest (Immunoglobins, Vaccines, Hematology, Cardiovascular Renal, Immunology & Transplant)
Proven experience in managing an in–house IP team, preferably in pharmaceutical or biotech field
Proven experience in due diligence, life cycle management, IP challenges and/or negotiations
This role may require travel, especially to CSL sites in Europe, US and Australia
Competencies:
Proven leadership skills, focused on building bridges and empowering teams.
Leadership competencies that include strategic thinking, integrating external factors into patent strategy, team building, talent cultivation, and coaching
Demonstrated business acumen with the ability to provide actionable and strategic advice. Ability to initiate, drive, lead and shape IP strategy
Excellent organizational and planning skills and ability to deliver work to tight deadlines (if required)
Capacity to foster environments that enhance decision–making and appropriate risk–taking, especially in patent–related matters.
Superior verbal and written communication skills, adept at simplifying complex concepts for business partners
Strong interpersonal skills with the capacity to effectively interact with diverse groups, key internal functions, senior management, external partners, and build great relationships with people across a global business
Agile learner, quickly adaptable to new situations and challenges.
Thinks beyond and incorporates external factors into business strategy
Builds bridges and empowers One–CSL teams
Unleashes outcomes and creates an environment of decision making and appropriate risk taking
Ignites agility and creates a nimble environment
Inspires the future and drives the strategy throughout the organization
Cultivates talent and takes proactive steps to secure future talent
Problems faced often complex and undefined, requiring broad–based solutions to implement changes for area of responsibility
Requires ability to influence others, negotiate and compromise, and ability to communicate and influence senior executive leadership
Disclaimer: The above statements describe the general nature and level of work and are not an exhaustive list of all required responsibilities, duties, and skills.
Our BenefitsCSL Seqirus employees that work at least 30 hours per week are eligible for benefits effective day 1. We are committed to the wellbeing of our employees and their loved ones. CSL Seqirus offers resources and benefits, from health care to financial protection, so you can focus on doing work that matters. Our benefits are designed to support the needs of our employees at every stage of their life. Whether you are considering starting a family, need help paying for emergency back up care or summer camp, looking for mental health resources, planning for your financial future, or supporting your favorite charity with a matching contribution, CSL Seqirus has many benefits to help achieve your goals.
Please take the time to review our benefits site to see what's available to you as a CSL Seqirus employee.
About CSL Seqirus CSL Seqirus is part of CSL Limited (ASX: CSL). As one of the largest influenza vaccine providers in the world, CSL Seqirus is a major contributor to the prevention of influenza globally and a transcontinental partner in pandemic preparedness. Learn more about CSL Seqirus . We want CSL Seqirus to reflect the world around usAs a global organization with employees in 35+ countries, CSL embraces diversity and inclusion. Learn more about Diversity & Inclusion at CSL Seqirus.
Do work that matters at CSL Seqirus!Watch our 'On the Front Line' video to learn more about CSL Seqirus